U.S. National Trends in the Use of Antipsychotics During Office Visits, 1998–2002

Authors: Aparasu, Rajender1; Bhatara, Vinod2; Gupta, Sanjay3

Source: Annals of Clinical Psychiatry (after Jan 1, 2004), Volume 17, Number 3, Number 3/July-September 2005 , pp. 147-152(6)

Publisher: Taylor and Francis Ltd

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Background . There is a paucity of studies on U.S. national trends in the use of antipsychotic medications in the 21st century. This study examined national trends in the prescribing of antipsychotic drugs in office-based physician practices. Methods . National probability sample survey data from 1998–2002 National Ambulatory Medical Surveys were used to analyze the prescribing trends. The weighted visit estimates and percentages were compared across the years using z-test. Results . The number of antipsychotic-related visits was found to increase significantly and nearly two-fold, from 4.6 million in 1998 to 8.6 million in 2002. During the same period, the number of visits for second-generation antipsychotic drugs nearly tripled. The proportion of visits for the second-generation agents, as a percentage of visits for all antipsychotic drugs, rose sharply from about 48% in 1998 to 84% in 2002. Correspondingly, the percentage of visits involving first-generation antipsychotic drugs declined. The growth in the number of visits involving antipsychotic drugs over the 5-year period was substantial (120%) in visits with non-psychiatrist physicians, but not in visits involving psychiatrists. Conclusions . The trend of growth in prescription of antipsychotic drugs in office visits, accounted by increased use of second-generation antipsychotics, has persisted into the 21st century. Increased prescribing of these agents by non-psychiatrists is also apparently fueling this trend. This trend of shift from first-to-second generation antipsychotic agents, though not unambiguously supported by extant safety and efficacy data, is endorsed by guidelines based on expert-consensus and limited data. Given the high-level use of second-generation drugs, more practical studies of these drugs, focusing on effectiveness or long-term outcomes, are needed.

Keywords: Antipsychotic; Trends; Office; Prescribing; Physicians

Document Type: Research article

DOI: 10.1080/10401230591002084

Affiliations: 1: Department of Pharmaceutical Sciences, College of Pharmacy, South Dakota State University, Brookings, SD, USA 2: University of South Dakota, School of Medicine, Sioux Falls, SD, USA 3: Olean General Hospital, Olean, NY, USA

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$45.29 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A